To the Editor: Beyond numerous studies examining suicide attempts and completions, the examination of broader types of self-harm behavior among various clinical samples has been fairly limited (eg, eating disorders, 1 gastric bypass patients 2 ). In this regard, we are aware of no studies examining various self-harm behaviors in patients seeking buprenorphine treatment-the focus of this study.
. As expected, the abuse of prescription medications (87%) and alcohol (71%) was very prevalent. In addition, nearly one-third of participants acknowledged either suicide attempts or intentional overdoses. Other intentional self-defeating behaviors in which at least one-quarter of the respondents reported having engaged included sexual promiscuity, losing a job on purpose, torturing oneself with self-defeating thoughts, distancing oneself from God, head-banging, setting oneself up in a relationship to be rejected, hitting oneself, cutting oneself, and making medical situations worse.
In previous analyses of this study population, we confirmed high rates of borderline personality disorder 4 and childhood trauma. 5 These variables are likely to be partially mediating the notably high rates of self-harm behavior that we observed in this study population of patients in treatment with buprenorphine.
The limitations of this study include the small sample size, self-report nature of the data, and limited ability to generalize the data to other types of populations.
However, this is the only study of which we are aware that has examined broad self-harm behaviors in an opioiddependent population; findings indicate notable rates. 
